Regional differences in patterns of urinary tract infections.
The identity of 693 pathogenic bacilli isolated from 2,175 urine specimens cultured during a two-year period in southeastern New Mexico is presented along with results of sensitivity testing by Kirby-Bauer technique.  The pattern of infections and sensitivity studies in hospitalized patients is compared with that of office patients and contrasted with results noted in other areas.
D002170:Canada; D002954:Citrobacter / Q000302:isolation & purification; D003091:Colistin / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D004812:Epidemiologic Methods; D004926:Escherichia coli / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D007709:Klebsiella / Q000302:isolation & purification; D008297:Male; D008826:Microbial Sensitivity Tests; D008910:Minnesota; D009268:Nalidixic Acid / Q000627:therapeutic use; D009516:New Mexico; D009582:Nitrofurantoin / Q000627:therapeutic use; D010414:Pennsylvania; D011511:Proteus / Q000302:isolation & purification; D011549:Pseudomonas / Q000302:isolation & purification; D014552:Urinary Tract Infections / Q000453:epidemiology / Q000382:microbiology*; D014556:Urine / Q000382:microbiology
D005839:Gentamicins; D009268:Nalidixic Acid; D009582:Nitrofurantoin; D003091:Colistin